Closing Bell: Nervgen Pharma Corp up on Monday (NGEN)

In market activity today, shares of Nervgen Pharma Corp opened at $2.85 and closed at $2.92. prices ranged from $2.84 to $2.96.

Shares gained 3.55 percent from the previous day's close of $2.82.

During the day across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 71,957 shares was traded during the last trading day, with total trades of 190. On average, Nervgen Pharma Corp has traded 42,449 shares over the last 5-days and 88,365 year-to-date.

The TSX-V market on the whole today saw 3,734 price advancers against 1,480 declines and 101 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 68.79 percent in the last 12 months, while they have advanced 8.15% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $197.19 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Based on 0.00 analysts, Nervgen Pharma Corp gets an average recommendation of "Strong Sell" according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..